ASX - By Stock
|
BOD |
Re:
Ann: Quarterly Activities Report / Appendix 4C
|
|
Covid2030
|
5 |
2.0K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
5
|
2.0K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Services Agreement with Code4 Cannabis
|
|
Covid2030
|
35 |
13K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
35
|
13K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Services Agreement with Code4 Cannabis
|
|
Covid2030
|
35 |
13K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
35
|
13K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Member's Statement
|
|
Covid2030
|
23 |
8K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
23
|
8K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Results of 2023 Annual General Meeting
|
|
Covid2030
|
9 |
5.6K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
9
|
5.6K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Vote for Ben Jansen
|
|
Covid2030
|
87 |
30K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
87
|
30K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Vote for Ben Jansen
|
|
Covid2030
|
87 |
30K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
87
|
30K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Vitura adds smoking cessation product vertical
|
|
Covid2030
|
14 |
5.8K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
14
|
5.8K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Canview Services Agreement not to be extended
|
|
Covid2030
|
17 |
9.1K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
17
|
9.1K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Change in substantial holding
|
|
Covid2030
|
19 |
6.3K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
19
|
6.3K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
38
|
18K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
38
|
18K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: CEO transition
|
|
Covid2030
|
18 |
7.7K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
18
|
7.7K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
Ann: CEO transition
|
|
Covid2030
|
18 |
7.7K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
18
|
7.7K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: CEO transition
|
|
Covid2030
|
18 |
7.7K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
18
|
7.7K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: CEO transition
|
|
Covid2030
|
18 |
7.7K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
18
|
7.7K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Trading Halt
|
|
Covid2030
|
4 |
1.7K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Trading Halt
|
|
Covid2030
|
4 |
1.7K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: CEO transition
|
|
Covid2030
|
18 |
7.7K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
18
|
7.7K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: CEO transition
|
|
Covid2030
|
18 |
7.7K |
4 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
18
|
7.7K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
38
|
18K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
38
|
18K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
38
|
18K
|
3
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Response to ASX Query
|
|
Covid2030
|
63 |
25K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
63
|
25K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
Ann: First supply of Psilocybin
|
|
Covid2030
|
19 |
8.0K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
19
|
8.0K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Shareholder update
|
|
Covid2030
|
27 |
17K |
1 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
27
|
17K
|
1
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Convening of Second Meeting of Creditors
|
|
Covid2030
|
8 |
2.9K |
1 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Response to ASX Query
|
|
Covid2030
|
63 |
25K |
5 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
63
|
25K
|
5
|
|
ASX - By Stock
|
IDT |
Re:
News: IDT IDT Australia Posts HY Revenue From Ordinary Activities And Other Income A$5.8 Mln
|
|
Covid2030
|
17 |
5.2K |
0 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
17
|
5.2K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
Ann: First supply of Psilocybin
|
|
Covid2030
|
19 |
8.0K |
3 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
19
|
8.0K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Further delay in lodgement of App.4D and Half Year Report
|
|
Covid2030
|
3 |
941 |
0 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
3
|
941
|
0
|
|
ASX - By Stock
|
VIT |
Re:
Ann: First supply of Psilocybin
|
|
Covid2030
|
19 |
8.0K |
4 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
19
|
8.0K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
Ann: First supply of Psilocybin
|
|
Covid2030
|
19 |
8.0K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
19
|
8.0K
|
2
|
|
ASX - By Stock
|
SIG |
Re:
General Discussion
|
|
Covid2030
|
96 |
55K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
96
|
55K
|
3
|
|
ASX - By Stock
|
CAN |
Re:
Another one bites the Dust
|
|
Covid2030
|
20 |
13K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
20
|
13K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
3 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
38
|
18K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Delay in lodgement of Appendix 4D and Half Year Report
|
|
Covid2030
|
5 |
1.8K |
0 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
5
|
1.8K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Change in substantial holding
|
|
Covid2030
|
19 |
6.3K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
19
|
6.3K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Change in substantial holding
|
|
Covid2030
|
19 |
6.3K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
19
|
6.3K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Suspension from Quotation
|
|
Covid2030
|
11 |
9.8K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
11
|
9.8K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Vitura Health acquires Doctors on Demand
|
|
Covid2030
|
29 |
9.7K |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
29
|
9.7K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
38
|
18K
|
3
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Cleansing Statement
|
|
Covid2030
|
21 |
6.0K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
21
|
6.0K
|
1
|
|
ASX - By Stock
|
LGP |
Re:
Ann: First Polish Shipment
|
|
Covid2030
|
2 |
1.8K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
2
|
1.8K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
38
|
18K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Covid2030
|
38 |
18K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
38
|
18K
|
4
|
|
ASX - By Stock
|
LGP |
Re:
Ann: Reset Offers withdrawn and Reset to remain LGP subsidiary
|
|
Covid2030
|
10 |
4.7K |
0 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
10
|
4.7K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Covid2030
|
4 |
1.5K |
3 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
4
|
1.5K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Appointment of Independent Chair
|
|
Covid2030
|
8 |
2.9K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Appointment of Independent Chair
|
|
Covid2030
|
8 |
2.9K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|